. Author manuscript; available in PMC: 2019 Jan 1.

Published in final edited form as: Endocrine. 2017 Dec 4;59(1):143–150. doi: 10.1007/s12020-017-1484-1

Table 2.

Clinico-pathologic features and outcome of patients with unifocal mPTC, NI-EFV compared to those with unifocal invasive forms of mPTC, follicular variant

		mPTC, NI-EFV	mPTC, follicular variant, invasive
Number of patients		52	57
Gender	Female	45 (87%)	48 (84%)
Gender	Male	7 (13%)	9 (16%)
Age, median (range)		52 (27 – 81)	51 (18 – 77)
Size, cm, median (range)		0.44 (0.1 – 0.9)	0.2 (0.03 – 0.9)
Surgical procedure	Lobectomy	23 (44%)	33 (58%)
Surgical procedure	Total thyroidectomy	29 (56%)	24 (42%)
Other non-malignant tumors	Adenoma/NIFTP	9 (17%)	10 (17%)
Other non-malignant tumors	None	45 (83%)	47 (83%)
Lymph node status	N1	0 (0%)	5 (9%)
	N0	20 (38%)	19 (33%)
	Nx	32 (62%)	33 (58%)
Follow up duration, years, median (range)		4.3 (1.0–18.1)	6.5 (0.4 – 23.3)
Disease status at last FU	NED	52 (100%)	39 (95%)
Disease status at last FU	Neck recurrence	0 (0%)	1 (2%)